Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression - Wikidata - awgldk - TriplyDB

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression

http://www.wikidata.org/entity/Q28144159

about

The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells Identification of disease-specific genes in chronic pancreatitis using DNA array technology Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis Expression and characterization of the FXYD ion transport regulators for NMR structural studies in lipid micelles and lipid bilayers Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines Progress in the application of DNA microarrays TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence Cancer biomarker discovery: the entropic hallmark.Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.Cellular and physiological roles for phospholipase D1 in cancer.Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.Discovering altered genomic expression patterns in heart: transcriptome determination by serial analysis of gene expression.Structural studies of apoptosis and ion transport regulatory proteins in membranes FXYD3: A Promising Biomarker for Urothelial Carcinoma.Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.Molecular phenotyping of the immune system by microarray analysis.'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens.Biological modulation by lectins and their ligands in tumor progression and metastasis.Overexpression of FXYD-3 is involved in the tumorigenesis and development of esophageal squamous cell carcinoma.Clinical and Therapeutic Implications of Follistatin in Solid Tumours.Follistatin as potential therapeutic target in prostate cancer.Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways.Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells.Serum follistatin in patients with prostate cancer metastatic to the bone.Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma.Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?Sex chromosome anomalies in pancreatic endocrine tumors

P2860

Q24534541-55396A5B-33C8-4654-8BB0-AAAA1F36F9E8 Q24541958-7E072598-800B-4B6D-AC40-36C4840910E0 Q24551021-C4D11DC6-019B-484A-B4EF-DD4201B1F5FB Q24595026-B1BA2435-F714-47F3-AA45-140CA1853115 Q24803829-6016766A-FB16-4718-A26F-B0BA4A9AA95A Q24813217-52FD8885-D340-45CF-BBFA-3F636E6DBFDD Q28201559-5202D655-448C-4803-93A5-54C3F98C9A27 Q30496149-132E6991-C0E6-48C8-8458-4E2EA3395F4C Q30724678-72F9BEC5-D3BE-4AD1-894A-DC884E537E65 Q31039506-7E302466-CA5F-4771-8757-9F45AF86AD62 Q33369059-F63814E0-E064-4B4D-8F1C-0F74FBCBF14A Q33520245-D2037F08-3919-4826-9E39-609AD89C2206 Q34044529-1B56459F-E2DD-4681-9272-84E54AA5358F Q34046037-7A47E2C8-C5FB-4D80-A786-88A6686C970D Q34264671-F069D0B5-982A-4BFC-B2A9-40A262AAE13D Q34549560-4EEC3A5E-2E9D-47EC-BC23-69C36002F14E Q34788904-BBE4DF83-E0E7-4992-B4E4-5DAE7C411327 Q35083279-89B20BF2-ECC9-4B8F-935E-72FCD16E9CB9 Q35126270-A892270B-377B-48A8-90B7-8808549ABD8E Q36610764-720333A1-739A-4F07-997F-17BF5621D828 Q37065281-C07D9F86-0F60-4628-879C-A5C7EFBAA066 Q37176638-1F1819E3-4043-4C24-A62B-1C9EB06B4327 Q37569979-4D9249A0-1705-4DC9-9967-66D57D778588 Q38086102-86B7A6E7-AC28-461D-A915-B27DCC00AF11 Q38160862-DA1BE74E-64E0-4641-88A7-E25BF1A5E72B Q38817649-B768A7D0-5A01-4274-B5F4-2F7F0E9D64F1 Q38860787-1358F836-658B-48A7-A837-58891F271C74 Q40373029-AB1EEE0D-DD5B-4EB1-BF0D-4856B904089D Q40741627-D066DC8B-F4C2-4301-A0AC-0137952A845D Q42972965-FEDBF055-74C2-4CF1-B9D0-A4D120B16368 Q43283331-409BA66C-A826-4259-AAD1-782AE4C19632 Q43824461-179661B1-4FC7-4749-BD27-F40228C8AF44 Q47805023-737A86AB-4DB8-46A9-8C6E-201C42C5572F Q49533065-2D04D814-2CEB-4AB5-821F-97BBCA5A66BA Q51904562-0E1CD703-9514-4023-9048-5177F3931635 Q57290104-77B6659C-85A7-4725-80CA-7F440699CBD2

P2860

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression

http://www.wikidata.org/entity/Q28144159

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Differentially expressed genes ...... ng prostate cancer progression

@ast

Differentially expressed genes ...... ng prostate cancer progression

@en

Differentially expressed genes ...... ng prostate cancer progression

@nl

type

label

Differentially expressed genes ...... ng prostate cancer progression

@ast

Differentially expressed genes ...... ng prostate cancer progression

@en

Differentially expressed genes ...... ng prostate cancer progression

@nl

prefLabel

Differentially expressed genes ...... ng prostate cancer progression

@ast

Differentially expressed genes ...... ng prostate cancer progression

@en

Differentially expressed genes ...... ng prostate cancer progression

@nl

P1433

Q28144159-68955DE2-88DC-4DAA-9311-87724FB23095

P1476

Q28144159-B8E143B2-6E54-40D1-9E5C-9597CE9E9D7E

P2093

Q28144159-16BA1002-8094-4487-AA09-3F2D64459628

Q28144159-6C62DA0A-3336-47FF-8333-1C35919C1538

Q28144159-A7063E15-C377-40B1-B8B7-B4E26E5E733E

Q28144159-C6A5AA00-7AE8-4D46-987F-4CB869E4FDAC

P2860

Q28144159-04B62ED2-522E-4702-AB9C-A310CCC5779F

Q28144159-162EF50D-F388-4EC6-B5C1-0AF71BBB1ABD

Q28144159-1FB0E531-8ACF-4192-95BC-1EC4BF566D3D

Q28144159-20043138-7848-449F-8C4A-A6D7F8B2A916

Q28144159-21EFE977-8306-45BF-9EA6-F07C39C97639

Q28144159-2E3AF042-9ECF-4E22-9F0A-2AE82967AAC8

Q28144159-3291D016-01EB-439F-8CB9-068C144195EE

Q28144159-452332E9-56AB-4225-B3CE-01B85CD63374

Q28144159-56F19678-C30B-4573-93FB-C4C152B47981

Q28144159-6590309B-A07B-4718-8354-CF60866E63E3

P2888

Q28144159-E74ABB36-0EED-4ABD-921E-898051A6A02E

P304

Q28144159-558DD265-ECDF-4C6E-ABA6-788019975AD3

P31

Q28144159-03F6031A-7EB4-4905-B146-B783B1C10AD9

P356

Q28144159-C27C55E2-B40E-4266-8BA7-045C6AA6A17F

P407

Q28144159-6873E414-9C78-482A-945E-9CECE3152C9C

P433

Q28144159-78878181-4EBE-4547-A027-B1EB423A4843

P478

Q28144159-4E3813AB-0126-476D-BAA6-B7745F3D9D0C

P577

Q28144159-3CDA9AB9-CFB3-4DF7-BBC6-949C883763F8

P5875

Q28144159-23484253-BB9F-4D8D-895B-9ACDDF0D5982

P6179

Q28144159-3CEF1EF4-0C21-4522-8C19-C428D1E1DB72

P698

Q28144159-6FF54C92-E676-4E12-80A4-29962D50BB4A

P356

LABINVEST.3780134

P1433

Laboratory Investigation

P1476

Differentially expressed genes ...... ng prostate cancer progression

@en

P2093

A Kyllönen

http://www.w3.org/2001/XMLSchema#string

K Porvari

http://www.w3.org/2001/XMLSchema#string

M H Vaarala

http://www.w3.org/2001/XMLSchema#string

P Vihko

http://www.w3.org/2001/XMLSchema#string

P2860

Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family

Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3

Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope

Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer.

Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations.

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.

Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death.

Antiangiogenic activity of prostate-specific antigen.

Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b.

P2888

labinvest.3780134

P304

1259-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3780134

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12370989

http://www.w3.org/2001/XMLSchema#string

P6179

1044958238

http://www.w3.org/2001/XMLSchema#string

P698

10950117

http://www.w3.org/2001/XMLSchema#string